Øyvind Kongstun Arnesen is appointed new chairman at Oslo Cancer Cluster (OCC).
Kongstun Arnesen is currently CEO of Ultimovacs and he takes over after Henrik Lund who opted not to stand for re-election after four years in the position.
“We look forward to having Øyvind as our chairman. He is very knowledgeable and enthusiastically committed to oncology research and development. His medical background combined with biotech entrepreneurship and years in the pharmaceutical industry, will help elevate Oslo Cancer Cluster to the next level,” says General Manager of Oslo Cancer Cluster Ketil Widerberg.
Photo of Øyvind Kongstun Arnesen: Charlotte Sverdrup